Literature DB >> 26782103

Efficacy of expiratory positive airway pressure nasal device.

Hao Wu1, Yongxiang Wei2.   

Abstract

Mesh：

Year:  2016        PMID： 26782103     DOI： 10.1007/s11325-015-1309-5

Source DB:  PubMed          Journal:  Sleep Breath        ISSN： 1520-9512            Impact factor:   2.816


× No keyword cloud information.
  4 in total

1.  Long-term use of a nasal expiratory positive airway pressure (EPAP) device as a treatment for obstructive sleep apnea (OSA).

Authors:  Meir H Kryger; Richard B Berry; Clifford A Massie
Journal:  J Clin Sleep Med       Date:  2011-10-15       Impact factor: 4.062

Review 2.  A review of EPAP nasal device therapy for obstructive sleep apnea syndrome.

Authors:  Hao Wu; Xiandao Yuan; Xiaojun Zhan; Li Li; Yongxiang Wei
Journal:  Sleep Breath       Date:  2014-09-23       Impact factor: 2.816

3.  The effects of Provent on moderate to severe obstructive sleep apnoea during continuous positive airway pressure therapy withdrawal: a randomised controlled trial.

Authors:  Valentina A Rossi; Barbara Winter; Najib M Rahman; Ly-Mee Yu; Janet Fallon; Christian F Clarenbach; Konrad E Bloch; John R Stradling; Malcolm Kohler
Journal:  Thorax       Date:  2013-05-30       Impact factor: 9.139

4.  A novel nasal expiratory positive airway pressure (EPAP) device for the treatment of obstructive sleep apnea: a randomized controlled trial.

Authors:  Richard B Berry; Meir H Kryger; Clifford A Massie
Journal:  Sleep       Date:  2011-04-01       Impact factor: 5.849
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.